INNODIA HARVEST: A Patient-Centered EU Project to Stop Type 1 Diabetes

April 16, 2020
Chantal Mathieu, head of the Leuven Diabetes Lab at KU Leuven, will coordinate the EU-funded INNODIA HARVEST project. This cutting-edge initiative focuses on patient-centered, biomarker-informed clinical trials designed to deepen our understanding of type 1 diabetes and accelerate the development of targeted prevention and treatment strategies.
Share this post

Project Summary

INNODIA HARVEST is an EU-funded initiative that builds on the foundations of the INNODIA consortium to develop innovative strategies for preventing or halting type 1 diabetes. The project brings together a large network of experts to conduct intervention trials that:

  • Study mechanisms of type 1 diabetes, including beta-cell destruction and immune pathways.
  • Identify biomarkers linked to disease development and progression.
  • Test beta-cell- and immune-focused interventions, aiming to generate knowledge for future combination therapies.
  • Create discovery pipelines for next-generation type 1 diabetes therapeutics.

Central to the project is the active involvement of people living with type 1 diabetes, ensuring that research and clinical trials are patient-centered and deliver outcomes with real-life impact.

‍

Support us

Choose to make a direct impact by contributing to a specific research project or by supporting the overarching goals of the Hippo & Friends Type 1 Diabetes Fund. 

By donating today, you enable early-career scientists to pursue groundbreaking research aimed at preventing and curing type 1 diabetes.
Every contribution moves us one step closer to breakthroughs that matter.

I want to make a direct donationI want to support Hippo & Friends